Skip to main content
ADBIOTECH Co.,Ltd. logo

ADBIOTECH Co.,Ltd. — Investor Relations & Filings

Ticker · 179530 ISIN · KR7179530001 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2025-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 179530

About ADBIOTECH Co.,Ltd.

http://www.adbiotech.com

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the development and commercialization of immune antibodies. The company's core competency is IgY (Immunoglobulin in Yolk) technology, which utilizes antibodies derived from eggs to create alternatives to conventional vaccines and antibiotics. Its product portfolio targets the livestock, aquaculture, and human health sectors, with applications for disease prevention and treatment in animals like salmon and shrimp, as well as human-focused developments for conditions related to Helicobacter pylori and cholesterol. The company manages the entire value chain from research and development to production and sales. ADBIOTECH is also expanding its technological capabilities into VHH (nanobody) technology, with a strategic focus on the global companion animal market.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is titled '반기보고서' (Semi-annual Report) for the company '애드바이오텍' (ADBIOTECH Co., Ltd.) covering the period from 2025-01-01 to 2025-06-30. It contains detailed company information, business descriptions, financial data, and management reports, which are characteristic of an interim/quarterly financial report. It is not a mere announcement or certification, as it provides substantive financial and operational details. H1 2025
2025-08-14 Korean
[기재정정]주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal 'Correction Report' (정정신고) regarding a 'Resolution for Convening a General Meeting of Shareholders' (주주총회소집결의). It details changes to the agenda for an upcoming Extraordinary General Meeting, including the appointment of directors, auditors, and the addition of new business purposes. This document is a regulatory filing required by the Korea Exchange (KRX) to inform shareholders of changes to meeting materials. It falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides the necessary information for shareholders to vote on the proposed agenda items.
2025-08-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (임시주주총회 소집공고) issued by Adbiotech. It contains the meeting agenda, date, location, and details regarding voting rights and director activities. This document is a formal notice and proxy-related material sent to shareholders to inform them of an upcoming meeting and the items to be voted upon, which aligns with the definition of a Proxy Solicitation & Information Statement.
2025-08-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Solicitation of Proxy' (의결권대리행사권유참고서류) filed by (주)애드바이오텍. It contains detailed information regarding an upcoming shareholder meeting, including the agenda (election of directors, auditors, and amendments to the articles of incorporation), proxy solicitation details, and candidate profiles. This document is a formal proxy statement used to request shareholder votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-08-14 Korean
파생상품거래손실발생
Capital/Financing Update Classification · 100% confidence The document is a regulatory disclosure regarding a 'Loss from Derivatives Transaction' (파생상품거래손실발생) filed by Addbiotech. It details the nature of the loss, the financial impact relative to equity, and the accounting reasons (fair value adjustment of convertible bonds). Since this is a specific regulatory disclosure of a material event that does not fit into the other specialized categories like M&A, dividends, or share repurchases, it falls under the general regulatory filing category.
2025-08-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when an entity or individual acquires or disposes of a significant stake (typically 5% or more) in a publicly traded company. This falls under the 'Major Shareholding Notification' category.
2025-08-12 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.